Literature DB >> 27951571

Fundamental Characteristics of the Newly Developed ATA™ Membrane Dialyzer.

Takashi Sunohara, Toshiaki Masuda.   

Abstract

BACKGROUND: Dialysis membranes are often made from synthetic polymers, such as polysulfone. However, membranes made from cellulose triacetate have superior biocompatibility and have been used since the 1980s. On-line hemodiafiltration treatment accompanied by massive fluid replacement is increasingly being used in Europe and Japan, but cellulose triacetate is not suitable for this treatment.
SUMMARY: Our newly developed asymmetric triacetate membrane, the ATA™ membrane, substantially improved the filtration properties and blood compatibility because of the asymmetric structure and smooth surface of this cellulose acetate membrane. Key Message: The ATA membrane maintains its high permeability even after massive filtration and shows less temporal variation in its permeation performance, lower protein adsorption, and superior biocompatibility compared with conventional membranes.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27951571     DOI: 10.1159/000451044

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  9 in total

1.  Asymmetric triacetate membrane keeps high water flux during ultrafiltration: in vitro study.

Authors:  Yoshihiro Tange; Shingo Takesawa; Shigenori Yoshitake
Journal:  J Artif Organs       Date:  2017-07-06       Impact factor: 1.731

2.  Semi-Quantitative Evaluation of Asymmetricity of Dialysis Membrane Using Forward and Backward Ultrafiltration.

Authors:  Akihiro C Yamashita; Toshiki Kakee; Takahisa Ono; Jun Motegi; Satoru Yamaguchi; Takashi Sunohara
Journal:  Membranes (Basel)       Date:  2022-06-15

3.  Thrombogenicity and long-term cytokine removal capability of a novel asymmetric triacetate membrane hemofilter.

Authors:  Andreas Körtge; Thomas Wild; Benjamin Heskamp; Manuel Folk; Steffen Mitzner; Reinhold Wasserkort
Journal:  J Artif Organs       Date:  2018-07-24       Impact factor: 1.731

4.  A randomized cross-over study with objective quantification of the performance of an asymmetric triacetate and a polysulfone dialysis membrane using different anticoagulation strategies.

Authors:  Floris Vanommeslaeghe; Iván Josipovic; Matthieu Boone; Annemie Dhondt; Wim Van Biesen; Sunny Eloot
Journal:  Clin Kidney J       Date:  2019-12-22

5.  Toxin Removal and Inflammatory State Modulation during Online Hemodiafiltration Using Two Different Dialyzers (TRIAD2 Study).

Authors:  Gabriele Donati; Maria Cappuccilli; Chiara Donadei; Matteo Righini; Anna Scrivo; Lorenzo Gasperoni; Fulvia Zappulo; Gaetano La Manna
Journal:  Methods Protoc       Date:  2021-04-22

6.  How biocompatible haemodialysers can conquer the need for systemic anticoagulation even in post-dilution haemodiafiltration: a cross-over study.

Authors:  Floris Vanommeslaeghe; Iván Josipovic; Matthieu Boone; Arjan van der Tol; Annemie Dhondt; Wim Van Biesen; Sunny Eloot
Journal:  Clin Kidney J       Date:  2020-12-08

7.  Impact of intradialytic fiber clotting on dialyzer extraction and solute removal: a randomized cross-over study.

Authors:  Floris Vanommeslaeghe; Iván Josipovic; Matthieu Boone; Wim Van Biesen; Sunny Eloot
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.379

Review 8.  Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy.

Authors:  Mario Bonomini; Luca Piscitani; Lorenzo Di Liberato; Vittorio Sirolli
Journal:  Biomedicines       Date:  2022-04-03

9.  Evaluation of Different Dialyzers and the Impact of Predialysis Albumin Priming in Intermittent Hemodialysis With Reduced Anticoagulation.

Authors:  Floris Vanommeslaeghe; Filip De Somer; Iván Josipovic; Matthieu Boone; Wim Van Biesen; Sunny Eloot
Journal:  Kidney Int Rep       Date:  2019-07-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.